Jeryl L. Hilleman - Jun 9, 2021 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role
Director
Signature
By: /s/ Steven Robbins, Attorney in Fact for Jeryl L. Hilleman
Stock symbol
NVCR
Transactions as of
Jun 9, 2021
Transactions value $
-$266,713
Form type
4
Date filed
6/11/2021, 04:21 PM
Next filing
Jun 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCR Restricted Stock Units Award $0 +814 +23.94% $0.00 4.21K Jun 9, 2021 Direct F1
transaction NVCR Ordinary Shares Disposed to Issuer -$267K -1.27K -30.14% $210.01* 2.94K Jun 9, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NVCR Options to Buy Ordinary Shares Award $0 +1.5K $0.00 1.5K Jun 9, 2021 Ordinary Shares 1.5K $211.89 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (1) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders.
F2 Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Ms. Hilleman.
F3 Options to buy 1,499 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2022 annual general meeting of shareholders.